Blue Owl Capital Inc. has completed the acquisition of a portfolio of private hospitals in the United Kingdom for £1.3 billion [1].
The deal marks a significant shift in ownership for these healthcare assets, moving them from a sovereign wealth fund to a private capital firm. This transition highlights the ongoing trend of institutional investment in the UK's private medical infrastructure.
According to reports, the seller of the portfolio was Malaysia's Employees Provident Fund [2]. The transaction involves a strategic transfer of healthcare facilities across the UK, though the specific number of hospitals was not detailed in the reports.
"Blue Owl Capital Inc has completed a deal to buy a portfolio of UK private hospitals from Malaysia's Employees Provident Fund," Reuters said [2].
To fund the purchase, the company utilized a new secured term loan [3]. This financial structure allows the firm to leverage the assets of the hospitals to manage the cost of the acquisition.
While the specific strategic goals of Blue Owl were not detailed in the transaction reports, the move aligns with broader efforts by global investment firms to secure stable, long-term yields in the healthcare sector. The acquisition was completed in July 2023 [2].
“Blue Owl Capital Inc. has completed the acquisition of a portfolio of private hospitals in the United Kingdom for £1.3 billion”
The transfer of healthcare infrastructure from a state-linked fund like the Employees Provident Fund to a private equity entity like Blue Owl underscores the increasing financialization of the UK's private health sector. By using a secured term loan to finance the £1.3 billion deal, Blue Owl is employing a leveraged strategy to gain a foothold in the European medical market, signaling a preference for tangible, high-value assets that can provide consistent returns despite broader economic volatility.
